IBM patents AI model for drug discovery

The U.S. Patent and Trademark Office granted IBM a patent for its drug discovery machine learning model.

Advertisement

The machine learning model, which received U.S. Patent 9,536,194, uses various information sources to identify links between drugs and their therapeutic value, along with their potential side effects.

IBM said its machine learning approach will help pharmaceutical researchers discover effective therapeutic drugs more quickly.

Click here to view the patent.

More articles on health IT:
ONC unveils $180k data challenge
Scripps Health goes live on Epic EHR
Intermountain Healthcare Innovation Fund invests $1M in Redox

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.